Zimmer Biomet Gets FDA OK for ROSA Hip System
August 18 2021 - 9:00AM
Dow Jones News
By Colin Kellaher
Zimmer Biomet Holdings Inc. on Wednesday said the U.S. Food and
Drug Administration approved the company's ROSA Hip System for
robotically-assisted direct anterior total hip replacement.
The Warsaw, Ind., musculoskeletal healthcare company said the
new product adds to a ROSA portfolio that already includes systems
for is total and partial knee arthroplasty, and for neurosurgical
and spine procedures.
Zimmer said ROSA Hip also enhances its ZBEdge suite of
integrated digital and robotic technologies.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
August 18, 2021 08:57 ET (12:57 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Zimmer Biomet (NYSE:ZBH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Zimmer Biomet (NYSE:ZBH)
Historical Stock Chart
From Apr 2023 to Apr 2024
